Paper on the future dementia research among the most cited in the world
The journal Lancet Neurology devoted its entire April issue in 2016 to a detailed overview and recommendations about how patient care, as well as basic and clinical research on Alzheimer disease and other dementias should be organized in the future. A year later the publication is among the most cited in the world.
The paper is a comprehensive report and the work of the Lancet Neurology Commission that was led by Professor Bengt Winblad, Department of Neurobiology, Care Sciences and Society (NVS) at Karolinska Institutet in Sweden. This commission was initiated by Lancet editors and formed with the aim to provide expert recommendations and information to politicians and policy makers about Alzheimer disease and related dementias.
The paper is now listed as a “hot” and a “highly cited paper”, which means that it is in the top 0.1 percentage of all papers in the past two years within the field of neuroscience and behavior.
“Our paper spans over the whole field and shows that a joint research effort within all parts of the dementia field is our great – and perhaps only – possibility to meet this “ticking cost bomb” and contribute to a better future for our patients and their families", says Bengt Winblad.
Defeating Alzheimer's disease and other dementias: a priority for European science and society.
Lancet Neurol 2016 Apr;15(5):455-532